

EuroBioImaging Bio-Hub Director and Head of Operations visit KU Leuven
On June 6th, Flanders BioImaging was delighted to host Antje Keppler and Ilari Pulli, who visited the VIB BioImaging Core, the Cell and...
Jun 5, 20241 min read


All-Hands EuroBioImaging Node Meeting, Torino
Flanders BioImaging attended the "All-Hands" Node meeting hosted by Euro-BioImaging in Torino, Italy. Held over 3 days, this event...
Apr 18, 20241 min read


Euro-BioImaging ERIC welcomes Spain and Belgium as new member states
Beglium joins the Euro-BioImaging ERIC
Jan 1, 20241 min read
Fast and directly correlated integration of light and electron microscopy
We developed a targeted approach that allows to image specific tissue features, like organelles, cell processes, and nuclei at different...
Jul 12, 20231 min read
Checking the mobility of a promising vision impairment therapeutic
Globally, over 2 billion people suffer from vision impairment. Deglycating enzyme fructosamine-3-kinase (FN3K) was recently proposed as a...
Jul 12, 20231 min read
Oral peptide delivery with nanocapsules
The delivery of therapeutic peptides via the oral route remains one of the biggest challenges in the pharmaceutical industry. Recently,...
Jul 12, 20231 min read
Tracking PEGylated rhDNase in lung tissue
In this paper, we investigated the mechanisms promoting the extended lung retention of PEG-rhDNase conjugates using cell culture models...
Jul 12, 20231 min read
A non-invasive marker for spinal cord injury damage
[11C]-UCB-J PET/CT imaging is a non-invasive marker for SV2A loss following spinal cord injury. SV2A PET may provide an objective measure...
Jul 12, 20231 min read
Imaging mutant huntingtin in the brain
[11C]CHDI-39 180R allowed for non-invasive monitoring of mHTT pathology in the brain and could track region and time-dependent...
Jul 12, 20231 min read
Promising biomarkers for Alzheimer's disease
Resting-state co-activation patterns are a promising candidate in the development of a diagnostic, and potentially, prognostic RS-fMRI...
Jul 12, 20231 min read

